Effects of Low Level Laser Therapy on the complications of CABG

Effects of Low Level Laser Therapy in comparison with laser therapy with none therapeutic power on the complications of Coronary Artery Bypass Surgery in patients with coronary artery stenosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016052926069N4

Enrollment

252

Registered

2016-08-25

Start date

2016-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery bypass grafting complications. -

Interventions

Intervention 1: Intervention group: Application of Intravenous and local Low level laser. Intravenous red laser, 655 nm, 1 mW for 15 minutes via cubital vain and local laser, infrared 780 nm, 200 mW,

Prevention

Placebo

Intervention group: Application of Intravenous and local Low level laser. Intravenous red laser, 655 nm, 1 mW for 15 minutes via cubital vain and local laser, infrared 780 nm, 200 mW, 6 J/Cm2 on the

control group: Application of intravenous and local Laser with none therapeutic power.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with stenosis in two or three coronary arteries (2VD/3VD) candidate for CABG. Exclusion criteria: renal chronic diseases; Hepatic chronic diseases; Diabetes; Cancer

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Atrial fibrilation. Timepoint: Before surgery, after surgery , daily until one week. Method of measurement: Electrocardiography, Ecocardiography.;Heart Failure. Timepoint: Before surgery, One week after surgery. Method of measurement: Electrocardiography, Ecocardiography.;Hypertrophic Scar. Timepoint: 3 to 6 months after surgery. Method of measurement: Vancouver Scar Scale Questionnaire.;Death. Timepoint: 3 to 6 months after surgery. Method of measurement: Reviewing patients medical records.;Needing Repetition of CABG. Timepoint: 3 to 6 months after surgery. Method of measurement: Reviewing patients medical records.	—

Measure

Time frame

Atrial fibrilation. Timepoint: Before surgery, after surgery , daily until one week. Method of measurement: Electrocardiography, Ecocardiography.;Heart Failure. Timepoint: Before surgery, One week after surgery. Method of measurement: Electrocardiography, Ecocardiography.;Hypertrophic Scar. Timepoint: 3 to 6 months after surgery. Method of measurement: Vancouver Scar Scale Questionnaire.;Death. Timepoint: 3 to 6 months after surgery. Method of measurement: Reviewing patients medical records.;Needing Repetition of CABG. Timepoint: 3 to 6 months after surgery. Method of measurement: Reviewing patients medical records.

—

Secondary

Measure	Time frame
Pericardial effusion. Timepoint: Before surgery, One week after surgery. Method of measurement: Electrocardiography, Ecocardiography.;Bleeding. Timepoint: 48 hours after CABG. Method of measurement: Measuring Suctioned blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNooshafarin Kazemikhoo

Skin and Stem Cell Research Center

nooshakazemi@gmail.com+98 212122212537

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 24, 2026